Sukino

Sukino successfully executes its aggressive expansion plan, opening over 30 new centers and effectively mitigating talent shortages through innovative training and retention programs. Strong partnerships with insurance providers and hospitals drive patient volume, pushing revenue to $50M+ by 2028 and justifying a $640M+ valuation at 12-14x revenue, establishing clear market leadership in India's post-hospital care segment.

Sukino maintains its strong growth trajectory and profitability, expanding to its target of 22 new centers over two years while managing competitive pressures and regulatory complexities. Revenue reaches $25M-$30M by 2028, leading to a $280M-$300M valuation at 10-12x revenue, reflecting steady execution and solidifying its position in the growing Indian out-of-hospital care market.

Severe talent shortages in physiotherapy and rehabilitation, coupled with aggressive expansion by large incumbent hospital chains into post-acute care, significantly slow Sukino's growth and erode market share. Regulatory hurdles and uncertain insurance coverage for neurorehabilitation lead to increased operational costs and reduced profitability. Revenue stalls at $15M-$20M, resulting in a down round or acquisition at a $60M-$80M valuation, which, given the $38M in liquidation preferences, would severely diminish or wipe out common stock value.